Having trouble finding Ongentys (Opicapone) at your pharmacy? Learn why this Parkinson's medication can be hard to find and what you can do about it in 2026.
If you or a loved one takes Ongentys (Opicapone) for Parkinson's disease, you may have experienced the frustration of showing up at your pharmacy only to hear, "We don't have that in stock." You're not alone. Many patients across the country have had trouble filling their Ongentys prescriptions, and the reasons may surprise you.
In this article, we'll explain what Ongentys is, why it can be hard to find, and — most importantly — what you can do to get your medication without the runaround.
Ongentys is the brand name for Opicapone, a once-daily capsule used alongside Levodopa/Carbidopa in people with Parkinson's disease who experience "off" episodes. Off episodes are times during the day when your Parkinson's symptoms return — things like stiffness, tremors, and difficulty moving — even though you're taking your regular medication.
Ongentys belongs to a class of drugs called COMT inhibitors. It works by blocking an enzyme called catechol-O-methyltransferase (COMT) that breaks down Levodopa in your body. By blocking this enzyme, Ongentys helps more Levodopa reach your brain, which means better symptom control and fewer off episodes. For more details, check out our guide on how Ongentys works.
Ongentys was approved by the FDA in April 2020 and is manufactured by Neurocrine Biosciences. It's the only once-daily COMT inhibitor available in the United States, which makes it a unique and important option for many Parkinson's patients.
There are several reasons you might have trouble finding Ongentys at your local pharmacy. Here are the most common ones:
Ongentys has no generic version available. The earliest a generic could come to market is after its patents expire in 2030. Because it's a brand-name drug prescribed to a relatively small patient population (people with Parkinson's disease experiencing off episodes), many pharmacies — especially large chain pharmacies — don't keep it on their shelves as a standard stock item.
Pharmacies typically stock medications based on demand. If only one or two patients in a given area use Ongentys, the pharmacy may not carry it routinely. This doesn't mean it's unavailable — it just means the pharmacy needs to order it.
Many insurance plans require prior authorization before they'll cover Ongentys. Some plans also require step therapy, meaning you may need to try a less expensive COMT inhibitor like Entacapone (Comtan) before your insurer will approve Ongentys. These extra steps can delay your ability to fill the prescription, making it feel like the drug is hard to get.
If your insurance requires prior authorization, your doctor's office will need to submit paperwork to your insurer. This process can take anywhere from a few days to a couple of weeks. Want tips on saving money? Read our guide on how to save money on Ongentys.
Because Ongentys is a relatively newer medication (approved in 2020) used for a specific condition, not every pharmacist is familiar with it. Some pharmacies may not have established ordering channels for it, or their wholesaler may need a day or two to deliver it. This can add unexpected wait times to filling your prescription.
The retail cash price of Ongentys can range from $645 to over $1,000 per month for a 30-day supply. This high price tag means pharmacies are cautious about stocking it without a confirmed prescription, since unsold inventory represents a significant financial risk. The cost can also deter patients from filling prescriptions if they don't have adequate insurance coverage.
The good news is that Ongentys is widely available through the pharmaceutical supply chain — it just may take a little extra effort to locate. Here's what you can do:
Medfinder lets you search for pharmacies near you that have Ongentys in stock. Instead of calling pharmacy after pharmacy, you can check availability online and save yourself time and frustration. Learn more in our article about how to find Ongentys in stock near you.
If your regular pharmacy doesn't have Ongentys on hand, ask them to order it for you. Most pharmacies can get specialty medications within 1 to 2 business days through their wholesaler. Some patients find it helpful to have their pharmacy place a standing order so the medication is always ready when they need a refill.
Independent pharmacies and specialty pharmacies often have more flexibility in ordering niche medications than large chain pharmacies. They may also provide more personalized service and be willing to keep Ongentys in stock for you on an ongoing basis.
Mail-order pharmacies can be a reliable option for ongoing prescriptions like Ongentys. Many insurance plans offer mail-order pharmacy benefits that may even save you money compared to retail. Your medication arrives at your door, eliminating the need to hunt for it at local pharmacies.
If insurance hurdles are the issue, work with your doctor's office to get prior authorization sorted out ahead of time. Neurocrine Biosciences also offers support through CoverMyMeds, a tool that helps streamline the prior authorization process. You can find more information at ongentys.com/support.
Finding Ongentys shouldn't be a full-time job — but for many Parkinson's patients, it can feel that way. The key things to remember are that Ongentys is not in a national shortage; it's just a specialty brand-name medication that not every pharmacy stocks routinely. With a little planning — using tools like Medfinder, working with your pharmacy, and getting insurance authorization squared away — you can get your Ongentys filled reliably.
If you're also exploring other treatment options, check out our article on alternatives to Ongentys or learn more about what Ongentys is and how it's used.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
